Screener
Niagen Bioscience NAGE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.32M+24.8% | $4.13M-42.4% | $4.58M+144% | $3.61M+24,160% | $5.06M+1,129% | ||
| $116K-26.6% | $139K-7.9% | $157K-4.3% | $158K-7.1% | $158K-11.2% | ||
| $1.72M+59.6% | $1.75M+132% | $1.76M+139% | $1.49M+25.6% | $1.08M+9.2% | ||
| -$1.19M-115% | $679K-92.1% | $3.69M+5.6% | $1.25M— | $7.88M+2,572% | ||
| $5.25M+16,491% | -$101K-46.4% | -$24K-14.3% | -$135K-1,025% | -$32K+22.0% | ||
| $2.35M— | —— | —— | —— | $0— | ||
| -$2.29M-174% | $0-100% | $148K-85.8% | $3.74M+528% | $3.11M+22,279% | ||
| $1.76M-83.9% | $498K-95.9% | $3.82M-15.4% | $4.86M+1,418% | $10.96M+4,465% |
FAQ
- How much cash does Niagen Bioscience generate?
- Niagen Bioscience (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.
- Where does Niagen Bioscience's cash flow data come from?
- Every line is extracted from Niagen Bioscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
